{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:06:34Z","timestamp":1792022794837,"version":"4.4.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T00:00:00Z","timestamp":1705104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T00:00:00Z","timestamp":1705104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s10620-024-08283-2","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T18:01:31Z","timestamp":1705168891000},"page":"892-900","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A Comprehensive Global Population-Based Analysis on the Coexistence of Eosinophilic Esophagitis and Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"69","author":[{"given":"Alexander","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin Douglas","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangru","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kaelber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5551-1818","authenticated-orcid":false,"given":"Gengqing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,13]]},"reference":[{"issue":"1","key":"8283_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jaci.2011.02.040","volume":"128","author":"CA Liacouras","year":"2011","unstructured":"Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: Updated consensus recommendations for children and adults. Journal of Allergy and Clinical Immunology. 2011;128(1):3\u201320.e6. doi:https:\/\/doi.org\/10.1016\/j.jaci.2011.02.040","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"8283_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","volume":"20","author":"YZ Zhang","year":"2014","unstructured":"Zhang YZ. Inflammatory bowel disease: Pathogenesis. WJG. 2014;20(1):91. doi:https:\/\/doi.org\/10.3748\/wjg.v20.i1.91","journal-title":"WJG"},{"issue":"4","key":"8283_CR3","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1053\/j.gastro.2009.07.007","volume":"137","author":"ME Rothenberg","year":"2009","unstructured":"Rothenberg ME. Biology and Treatment of Eosinophilic Esophagitis. Gastroenterology. 2009;137(4):1238\u20131249. doi:https:\/\/doi.org\/10.1053\/j.gastro.2009.07.007","journal-title":"Gastroenterology"},{"issue":"6","key":"8283_CR4","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1053\/j.gastro.2011.02.016","volume":"140","author":"W Strober","year":"2011","unstructured":"Strober W, Fuss IJ. Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases. Gastroenterology. 2011;140(6):1756\u20131767.e1. doi:https:\/\/doi.org\/10.1053\/j.gastro.2011.02.016","journal-title":"Gastroenterology"},{"issue":"12","key":"8283_CR5","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1136\/gutjnl-2018-318074","volume":"68","author":"BN Limketkai","year":"2019","unstructured":"Limketkai BN, Shah SC, Hirano I, Bellaguarda E, Colombel JF. Epidemiology and implications of concurrent diagnosis of eosinophilic oesophagitis and IBD based on a prospective population-based analysis. Gut. 2019;68(12):2152\u20132160. doi:https:\/\/doi.org\/10.1136\/gutjnl-2018-318074","journal-title":"Gut"},{"key":"8283_CR6","doi-asserted-by":"publisher","unstructured":"Sato H, Osonoi K, Shoda T. Genetic and Molecular Contributors in Eosinophilic Esophagitis. Current Allergy and Asthma Reports. Published online April 21, 2023. doi:https:\/\/doi.org\/10.1007\/s11882-023-01075-0","DOI":"10.1007\/s11882-023-01075-0"},{"issue":"1","key":"8283_CR7","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1038\/ncomms6593","volume":"5","author":"PMA Sleiman","year":"2014","unstructured":"Sleiman PMA, Wang ML, Cianferoni A, et al. GWAS identifies four novel eosinophilic esophagitis loci. Nat Commun. 2014;5(1):5593. doi:https:\/\/doi.org\/10.1038\/ncomms6593","journal-title":"Nat Commun"},{"issue":"4","key":"8283_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41435-018-0034-z","volume":"20","author":"LC Kottyan","year":"2019","unstructured":"Kottyan LC, Maddox A, Braxton JR, et al. Genetic variants at the 16p13 locus confer risk for eosinophilic esophagitis. Genes Immun. 2019;20(4):281\u2013292. doi:https:\/\/doi.org\/10.1038\/s41435-018-0034-z","journal-title":"Genes Immun"},{"issue":"4","key":"8283_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000497236","volume":"3","author":"YC Fan","year":"2018","unstructured":"Fan YC, Steele D, Kochar B, Arsene D, Long MD, Dellon ES. Increased Prevalence of Esophageal Eosinophilia in Patients with Inflammatory Bowel Disease. Inflamm Intest Dis. 2018;3(4):180\u2013186. doi:https:\/\/doi.org\/10.1159\/000497236","journal-title":"Inflamm Intest Dis"},{"issue":"3","key":"8283_CR10","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cgh.2020.02.015","volume":"19","author":"A Sonnenberg","year":"2021","unstructured":"Sonnenberg A, Turner KO, Genta RM. Comorbid Occurrence of Eosinophilic Esophagitis and Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology. 2021;19(3):613\u2013615.e1. doi:https:\/\/doi.org\/10.1016\/j.cgh.2020.02.015","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"8283_CR11","unstructured":"Where do TriNetX data come from? TriNetX. Published April 2021. Accessed April 21, 2023. https:\/\/support.trinetx.com\/hc\/en-us\/articles\/360004265733-Where-do-TriNetX-data-come-from"},{"issue":"8","key":"8283_CR12","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. Ann Intern Med. 2007;147(8):573. doi:https:\/\/doi.org\/10.7326\/0003-4819-147-8-200710160-00010","journal-title":"Ann Intern Med"},{"issue":"15","key":"8283_CR13","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1001\/jama.2015.13480","volume":"314","author":"JS Haukoos","year":"2015","unstructured":"Haukoos JS, Lewis RJ. The Propensity Score. JAMA. 2015;314(15):1637. doi:https:\/\/doi.org\/10.1001\/jama.2015.13480","journal-title":"JAMA"},{"issue":"7422","key":"8283_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature11582","volume":"491","author":"L Jostins","year":"2012","unstructured":"Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491(7422):119\u2013124. doi:https:\/\/doi.org\/10.1038\/nature11582","journal-title":"Nature"},{"issue":"12","key":"8283_CR15","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/ng.489","volume":"41","author":"M Imielinski","year":"2009","unstructured":"Imielinski M, Baldassano RN, Griffiths A, et al. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet. 2009;41(12):1335\u20131340. doi:https:\/\/doi.org\/10.1038\/ng.489","journal-title":"Nat Genet"},{"issue":"2","key":"8283_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/ajg.2011.342","volume":"107","author":"SL Sperry","year":"2012","unstructured":"Sperry SL, Woosley JT, Shaheen NJ, Dellon ES. Influence of Race and Gender on the Presentation of Eosinophilic Esophagitis. American Journal of Gastroenterology. 2012;107(2):215\u2013221. doi:https:\/\/doi.org\/10.1038\/ajg.2011.342","journal-title":"American Journal of Gastroenterology"},{"key":"8283_CR17","doi-asserted-by":"publisher","first-page":"175628482110066","DOI":"10.1177\/17562848211006669","volume":"14","author":"G Privitera","year":"2021","unstructured":"Privitera G, Pugliese D, Lopetuso LR, et al. Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches. Therap Adv Gastroenterol. 2021;14:175628482110066. doi:https:\/\/doi.org\/10.1177\/17562848211006669","journal-title":"Therap Adv Gastroenterol"},{"issue":"12","key":"8283_CR18","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1093\/ibd\/izz059","volume":"25","author":"DR Berg","year":"2019","unstructured":"Berg DR, Colombel JF, Ungaro R. The Role of Early Biologic Therapy in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 2019;25(12):1896\u20131905. doi:https:\/\/doi.org\/10.1093\/ibd\/izz059","journal-title":"Inflammatory Bowel Diseases"},{"issue":"10","key":"8283_CR19","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.jtho.2021.06.024","volume":"16","author":"J Luo","year":"2021","unstructured":"Luo J, Beattie JA, Fuentes P, et al. Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse Events. Journal of Thoracic Oncology. 2021;16(10):1759\u20131764. doi:https:\/\/doi.org\/10.1016\/j.jtho.2021.06.024","journal-title":"Journal of Thoracic Oncology"},{"issue":"3","key":"8283_CR20","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/MPG.0000000000003002","volume":"72","author":"H Moore","year":"2021","unstructured":"Moore H, Wechsler J, Frost C, et al. Comorbid Diagnosis of Eosinophilic Esophagitis and Inflammatory Bowel Disease in the Pediatric Population. Journal of Pediatric Gastroenterology & Nutrition. 2021;72(3):398\u2013403. doi:https:\/\/doi.org\/10.1097\/MPG.0000000000003002","journal-title":"Journal of Pediatric Gastroenterology & Nutrition"},{"key":"8283_CR21","unstructured":"Medicaid Drug Utilization Data 2019. Published online February 2021. Accessed April 18, 2023. https:\/\/data.medicaid.gov\/dataset\/6165f45b-ca93-5bb5-9d06-db29c692a360\/data"},{"key":"8283_CR22","unstructured":"Medicare Monthly Enrollment. Published online December 2022. Accessed April 18, 2023. https:\/\/data.cms.gov\/summary-statistics-on-beneficiary-enrollment\/medicare-and-medicaid-reports\/medicare-monthly-enrollment"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08283-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08283-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08283-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T18:05:09Z","timestamp":1711217109000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08283-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,13]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["8283"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08283-2","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,13]]},"assertion":[{"value":"15 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We adhere to ethical and legal guidelines for data access and protection. Depending on the nature of the data and any applicable privacy or legal restrictions, we may provide access to the data upon reasonable request. Requests for data access can be directed to the corresponding author.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Transparency statement"}},{"value":"The authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study explored links between Eosinophilic Esophagitis (EoE) and Inflammatory Bowel Disease (IBD). Simultaneous EoE and IBD increased IBD-related complications risk, needing more treatment (glucocorticoids, biologic therapy, abdominal surgery), while reducing EoE-related issues like food bolus impaction.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Summary"}}]}}